Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.

Satake N, Duong C, Yoshida S, Oestergaard M, Chen C, Peralta R, Guo S, Seth PP, Li Y, Beckett L, Chung J, Nolta J, Nitin N, Tuscano JM

Open source

DOI: 10.2119/molmed.2015.00210
Published: 2016 Oct
Container: Molecular medicine (Cambridge, Mass.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2119/molmed.2015.00210,
  title = {Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.},
  author = {Satake N and Duong C and Yoshida S and Oestergaard M and Chen C and Peralta R and Guo S and Seth PP and Li Y and Beckett L and Chung J and Nolta J and Nitin N and Tuscano JM},
  year = {2016},
  journal = {Molecular medicine (Cambridge, Mass.)},
  doi = {10.2119/molmed.2015.00210},
  url = {https://doi.org/10.2119/molmed.2015.00210}
}

RIS

TY  - JOUR
TI  - Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.
AU  - Satake N
AU  - Duong C
AU  - Yoshida S
AU  - Oestergaard M
AU  - Chen C
AU  - Peralta R
AU  - Guo S
AU  - Seth PP
AU  - Li Y
AU  - Beckett L
AU  - Chung J
AU  - Nolta J
AU  - Nitin N
AU  - Tuscano JM
PY  - 2016
JO  - Molecular medicine (Cambridge, Mass.)
DO  - 10.2119/molmed.2015.00210
UR  - https://doi.org/10.2119/molmed.2015.00210
ER  -

APA

N, S., C, D., S, Y., M, O., C, C., R, P., S, G., PP, S., Y, L., L, B., J, C., J, N., N, N., & JM, T. (2016). Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.2119/molmed.2015.00210

Source records

pubmed · retrieved 2026-09-26T12:53:02.085Z